[Antidiabetic biguanides and lactic acidosis].
Rojas Hidalgo
E
E
Servicio de Nutrición, Clínica Puerta de Hierro, Madrid.
D000140:Acidosis, Lactic / Q000139:chemically induced* / Q000378:metabolism; D001645:Biguanides / Q000009:adverse effects*; D002026:Buformin / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008954:Models, Biological; D010629:Phenformin / Q000009:adverse effects; D013453:Sulfonylurea Compounds / Q000009:adverse effects
D001645:Biguanides; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D010629:Phenformin; D002026:Buformin